cmi_logo.png
[Latest] Global Point of Care Glucose Testing Market Size/Share Worth USD 5,455.3 Million by 2033 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 27, 2024 01:30 ET | Custom Market Insights
Austin, TX, USA, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Point of Care Glucose Testing Market Size, Trends and Insights By Product (Accu...
cmi_logo.png
[Latest] US Diabetes Devices Market Size/Share Worth USD 19.8 Billion by 2033 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 23, 2024 13:30 ET | Custom Market Insights
Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Diabetes Devices Market Size, Trends and Insights By Type (Blood Glucose...
logo.png
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR
June 13, 2024 09:19 ET | GlucoTrack, Inc.
Completion of the novel epidural continuous glucose monitoring study confirms its potential for providing simplified disease management for patients with painful diabetic neuropathy Rutherford, NJ,...
Clinical ink announc
Clinical ink announces GlucoseReady™
April 23, 2024 08:00 ET | Clinical Ink
Winston Salem, NC, April 23, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today announced the launch of GlucoseReady™, a fully integrated GCP compliant digital...
LOGO.png
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
November 21, 2023 08:30 ET | Nemaura Medical, Inc
Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital...
logo.png
GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE
November 13, 2023 09:00 ET | GlucoTrack, Inc.
Rutherford, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
TIP_link_300x300.jpg
Durable Medical Equipment Market Size to Hit $291.52 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners
September 20, 2023 10:29 ET | The Insight Partners
Pune, India, Sept. 20, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Durable Medical Equipment Market Forecast to 2027 – Global Analysis – by Device Type (Personal Mobility Devices...
LOGO.png
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
September 12, 2023 09:26 ET | Nemaura Medical, Inc
LOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
LOGO.png
Nemaura Medical Announces SFDA Approval of sugarBEAT®
August 17, 2023 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
August 11, 2023 16:05 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...